Calcium-and integrin-binding protein 1 (CIB1) is involved in the process of platelet aggregation by binding the cytoplasmic tail of the ␣ IIb subunit of the platelet-specific integrin ␣ IIb ␤ 3 . Although poorly understood, it is widely believed that CIB1 acts as a global signaling regulator because it is expressed in many tissues that do not express integrin ␣ IIb ␤ 3 . We report the structure of human CIB1 to a resolution of 2.3 Å, crystallized as a dimer. The dimer interface includes an extensive hydrophobic patch in a crystal form with 80% solvent content. Although the dimer form of CIB1 may not be physiologically relevant, this intersubunit surface is likely to be linked to ␣ IIb binding and to the binding of other signaling partner proteins. The C-terminal domain of CIB1 is structurally similar to other EF-hand proteins such as calmodulin and calcineurin B. Despite structural homology to the C-terminal domain, the N-terminal domain of CIB1 lacks calcium-binding sites. The structure of CIB1 revealed a complex with a molecule of glutathione in the reduced state bond to the N-terminal domain of one of the two subunits poised to interact with the free thiol of C35. Glutathione bound in this fashion suggests CIB1 may be redox regulated. Next to the bound GSH, the orientation of residues C35, H31, and S48 is suggestive of a cysteine-type protein phosphatase active site. The potential enzymatic activity of CIB1 is discussed and suggests a mechanism by which it regulates a wide variety of proteins in cells in addition to platelets.
recruit more platelets to form a hemostatic plug. In this plug, platelets are cross-linked through fibrinogen binding to integrin ␣ IIb ␤ 3 (also known as GPIIb/IIIa), the platelet fibrinogen receptor (Weiss et al. 1991 ). This integrin is in a low affinity state on circulating platelets where it is exclusively expressed. Upon activation by an agonist through inside-out signaling ␣ IIb ␤ 3 is rapidly converted to a high affinity state capable of binding soluble fibrinogen Shattil et al. 1998) . This binding triggers an outside-in signaling cascade through integrin ␣ IIb ␤ 3 that initiates a cascade of signaling leading to platelet aggregation (Aplin et al. 1998) . While a number of proteins have been shown to interact with the ␣ IIb ␤ 3 cytoplasmic tails (Rojiani et al. 1991; Shattil et al. 1995; Hannigan et al. 1996; Law et al. 1996; Tadokoro et al. 2003) , how they regulate bidirectional signaling through the integrin is not well understood.
We previously identified calcium-and integrin-binding protein 1 (CIB1) and showed that it binds to the cytoplasmic tail of the integrin ␣ IIb subunit in a calcium-dependent manner Shock et al. 1999) . Although CIB1 has been shown to activate integrin ␣ IIb ␤ 3 (Tsuboi 2002) , recent reports indicate that CIB1 may be involved in outside-in signaling (Vallar et al. 1999; Naik and Naik 2003a,b) . When platelets are activated by agonists, such as thrombin or collagen, CIB1 translocates to the cytoskeleton in an aggregation-dependent manner (Shock et al. 1999) . Once the activated ␣ IIb ␤ 3 binds to the ligand, CIB1 in turn binds to the integrin's cytoplasmic tail forming a complex (Shock et al. 1999) . This interaction between CIB1 and ␣ IIb ␤ 3 is required for platelet spreading on immobilized fibrinogen (Naik and Naik 2003a,b) . CIB1, which shares significant homology with calcineurin B (CnB) and calmodulin (CaM), contains four calcium binding EF-hand motifs. Only the two most C-terminal are predicted to be functional, EF-hands 3 and 4 Stabler et al. 1999) . Like CaM, experimental observations have suggested that CIB1 also changes its conformation considerably with calcium binding (Yamniuk et al. 2004 ).
Studies have also described CIB1 in multiple tissues that do not express ␣ IIb ␤ 3 , suggesting that CIB1 may play a wider regulatory role (Shock et al. 1999; Stabler et al. 1999 ). Since our original report describing the discovery of CIB1 and its interaction with ␣ IIb ␤ 3 , it has been shown that CIB1 also binds to a number of other proteins (Wu and Lieber 1997; Kauselmann et al. 1999; Stabler et al. 1999; Haataja et al. 2002; Whitehouse et al. 2002; Ma et al. 2003) . Notably among these proteins are focal adhesion kinase, presenilin 2, polo-like kinase 2 and 3, Rac3, and DNA-dependent protein kinase (Wu and Lieber 1997; Kauselmann et al. 1999; Stabler et al. 1999; Haataja et al. 2002; Ma et al. 2003; Naik and Naik 2003a) . It is not clear how CIB1 associates, and possibly regulates, proteins with such diverse functions. To gain insight into how CIB1 regulates these signaling proteins, other laboratories have modeled CIB1 based on its known homology to the CaM family of calcium-binding proteins (Hwang and Vogel 2000; Barry et al. 2002) . In order to better understand the role of CIB1, we felt it was necessary to understand the molecular structure of this protein. We therefore initiated studies to elucidate the X-ray structure of CIB1.
Here we report the crystal structure of a calcium bound form of human CIB1 to a resolution of 2.3 Å. As expected the structure of CIB1 is homologous to CnB and CaM. The greatest structural similarity is in the C-terminal domain, which contains two EF-hand motifs, like those found in CaM. In addition to presenting the structure of CIB1, we predict the interactions of CIB1 responsible for binding to the ␣ IIb subunit cytoplasmic tail. The N-terminal domain of our structure also revealed a coordinated molecule of reduced glutathione (GSH) and a putative cysteine-type phosphatase active site. The GSH-binding site resides just outside the putative active site and suggests a redox regulated component to CIB1's function.
Results and Discussion

Overall structure of CIB1
The final model of human ⌬ −1-8 -CIB1 is a homodimer solved to a resolution of 2.3 Å (Fig. 1) . Each subunit contains 183 amino acid residues (residues 9-191 of full-length CIB1) and is made up of mostly ␣-helices with a small two stranded ␤-sheet in the N-terminal domain. A summary of the X-ray data collection and refinement of CIB1 is presented in Tables 1 and 2 . An additional surprise of the crystal structure was the presence of a bound molecule of GSH. The C-terminal domain of CIB1 contains two functional EF-hand motifs (EF-hand 3 and 4) bound to calcium as previously predicted Stabler et al. 1999) . The N-terminal domain EF-hands 1 and 2 vary considerably from functional EF-hands rendering them nonfunctional. Both are missing key aspartic acid residues at 38, 40, and 42 along with 78, 80, and 87 for EF-hand 1 and 2, respectively, plus EF-hand 1 contains an additional loop, residues 43-50.
Within a monomer, the N-and C-terminal domains are distinct from each other. The space between the domains is occupied by water, making CIB1, at first glance, resemble CaM and CnB. A structurally corrected sequence alignment of the entire CIB1 molecule showed no significant homology to other structures. However, alignments of the C-terminal domain alone did share a perceptible homology with parts of both CaM and CnB shown in Fig. 2A . Although, the N-terminal domain shares the protein fold similarity with its C-terminal end with an aligned RMSD of 1.67 Å (Fig. 2B) , it does not contain calcium-binding sites so its structural similarity with other calcium binding proteins was low.
CIB1 crystallizes as a dimer
The oligomeric state of CIB1 under physiological conditions is still an open question. Despite an extremely high solvent content of 80%, which is often linked to limited crystal contacts, chain A and B of CIB1 share an extensive contact surface (Fig. 1 ). Typically such an extensive interface points to a physiologically relevant interacting surface of a protein, thus suggesting a possible dimerization during the physiological lifetime of CIB1. The dimer is formed in a head-to-tail fashion with pseudosymmetric interactions from a hydrophobic patch of both the N and C terminus of CIB1. These hydrophobic surfaces are displayed as ball and stick ( Fig. 1B) and as an electrostatic potential surface (Fig.  1C) . CIB1 may form a dimer to prevent aggregation via this extensive hydrophobic surface (Fig. 1B) in the absence of a physiological binding partner. Alternatively, the dimerization found in the crystal may be an anomaly linked to the high protein concentration of crystallization trials (1 mM) and the crystal contact forces that exist between molecules. It is expected that interaction of CIB1 with physiological partners, such as the cytoplasmic tail of integrin ␣ IIb , would be exclusively mediated as a monomer since there is no evidence so far as we are aware that CIB1 acts as a dimer. The connection between the N-and C-terminal domains of one monomer spans the domains in a flexible fashion near the dimer interface. Therefore it is reasonable to consider that one CIB1 subunit could fold back on itself with the hydrophobic surfaces from both the N-and C-terminal domains contributing to a functionally relevant interaction. This conformational rearrangement would be analogous to the current model for CaM binding to its signaling partners. It is noteworthy that at lower concentrations (0.15 mM) and in the absence of a physiological binding partner, CIB1 was shown to have a hydrodynamic radius similar to monomeric proteins of a comparable size (Weljie et al. 2003) . Regardless of the functional significance of a CIB1 dimer, the surface of the protein highlighted by this extensive subunitsubunit interface is likely to be critical for CIB1 binding its functionally relevant partners, such as the cytoplasmic tail of ␣ IIb subunit. F21, F69, I73, V76, F77, V97, F98, P104) . Also shown in the N-terminal domain is a patch of negative charged residues in red ball and stick (E89, E90, E93). (C) The electrostatic potential of the subunit interface surface of chain A is displayed in the identical view to B using the program GRASP (Honig and Nicholls 1995) . The surface is colored according to convention with red indicating negative charge, blue positive charge, and white net neutral charge. The electrostatic potential surface further highlights the hydrophobic patch of the N-and C-terminal domains, as well as the same negative patch indicated in B of the N-terminal domain surface.
CIB1-␣ IIb cytoplasmic tail binding surface
CIB1 has been shown to functionally bind to the cytoplasmic tail of the integrin ␣ IIb from residue 983-997, which corresponds to the sequence LVLAMWKVGFFKRNR. These ␣ IIb tail residues are a mix of hydrophobic and positively charged residues. This leads one to look for a complementary surface on CIB1 that is directly involved in ␣ IIb tail binding. The hydrophobic patch on the C terminus of CIB1 (I106, Y110, I114, F115, F117, A184, F187) contains a few of the residues (I114, F115, F117) that were previously shown to bind the ␣ IIb tail by modeling and mutagenesis studies (Barry et al. 2002) . However, the majority of these residues (L131, V132, L135, L152, I153, F173, I177) are in the hydrophobic core of CIB1's C-terminal domain and are not likely to be directly involved in ␣ IIb tail recognition. An additional region revealed to be critical for ␣ IIb tail binding from in vivo experiments with a peptide corresponds to the C-terminal region of CIB1 from residue 179-188 (Tsuboi is the calculated amplitude. R free is the equivalent of R working , except it is calculated for a randomly chosen set of reflections (5%) that were omitted from the refinement process (Brunger 1992) . 2002). Although this region only contains two residues on the hydrophobic surface of CIB1 (A184 and F187, Fig. 1B ), the C terminus is solvent exposed, adjacent to the hydrophobic region and therefore likely to have important interactions with the ␣ IIb tail. The hydrophobic surface of CIB1 shown in Figure 1 , B and C, extends to the N-terminal domain, and therefore may also participate in ␣ IIb tail binding. In addition to the extension of the hydrophobic patch, the N-terminal domain contains a patch of negative charge (Fig. 1B , red residues) on this surface that may associate with positively charged residues of the ␣ IIb tail.
Although it is difficult to predict precisely how and in what orientation CIB1 binds the ␣ IIb tail on platelets, the surface of CIB1 discussed above is consistent with the expected functional binding area for ␣ IIb (Barry et al. 2002) . CIB1 has been shown to be N-terminally myristoylated, and therefore membrane anchored (Stabler et al. 1999; Barry et al. 2002) . Although our structure of ⌬ −1-8 -CIB1 lacks the first eight amino acids, which includes the putative myristoylation site, it does not appear from the position of the N terminus (Fig. 1A,B ) that this region would interfere with the surface discussed above to interact with the ␣ IIb tail. We performed intrinsic tryptophan fluorescence studies to show that deletion of these amino acids did not affect the binding of ⌬ −1-8 -CIB1 to the ␣ IIb tail (data not shown). Although our results show that myristoylation and N-terminal residues are not required for ␣ IIb -peptide binding, it is possible that wild-type protein with a membrane anchor may be needed for CIB1 to bind key residues of ␣ IIb , which are thought to be buried in the membrane (Armulik et al. 1999; Barry et al. 2002) . The demonstrated binding of CIB1 to this putative membrane buried region (Barry et al. 2002 ) is significant, as it is tied to a recent model of integrin signaling, which has been proposed to be mediated by a conformational tilting of the transmembrane domains of the integrin, thereby leading to the intracellular exposure of what were previously membrane buried residues (Stefansson et al. 2004) . Although speculative at this point, CIB1 binding to these residues on the ␣ IIb tail may be critical in integrin signaling.
The EF-hand 4 in the C-terminal domain of CIB1 may be setup to control target protein binding in a manner analogous to CaM. It has been reported that the greatest structural change occurs when EF-hand 4 becomes occupied, thereby stabilizing significant secondary and tertiary structure (Yamniuk et al. 2004 ). The residue responsible for calcium specificity at EF-hand 4, E172 (Yamniuk et al. 2004) , is adjacent to the hydrophobic core residue F173; this could be the determining signal to setup the hydrophobic-binding surface for its functional interaction. These predictions await the structural determination of a CIB1-target protein complex. It should be noted that crystal screening with a peptide corresponding to the recognition sequence of the ␣ IIb tail has only yielded small crystals of poor quality, perhaps due to the limited solubility of the CIB1-␣ IIb complex.
GSH-binding site and possible CIB1 activities
After placing the complete model of CIB1 protein atoms, a large area of positive electron density on chain B remained. Reviewing the CIB1 purification conditions led us to hypothesize that a molecule of GSH was bound at this site. The free thiol group of GSH faces the free thiol group of C35 and the sulfur atoms are 6 Å apart (Fig. 3A) . Further scrutiny of the difference electron density map revealed positive electron density between the C35 side chain and ultimately joining the imidazole ring of H31. Initially, this was modeled as cysteine sulfenic acid. In a recent report (Barrett et al. 1999a ), a redox regulatory mechanism is described in which an active site cysteine is oxidized to cysteine sulfenic acid and then reduced to the free sulfhydryl active form by GSH. We originally predicted the cysteine The GSH-binding site on the N-terminal domain of chain B is displayed relative to H31, C35, a bound water that sits between these residues, and the thiol of GSH. A hydrogen bond of 2.8 Å bridges the cysteine amide of GSH and the backbone carbonyl of L49 of CIB1. A difference electron density map (2Fo-Fc) is displayed around the bound water and GSH. (B) The alignment of the N-terminal domains of chain A (yellow) and the GSH bound chain B (blue) of CIB1. The binding of GSH causes the loop (residues 39-51) to lose helical character and adopt an alternate conformation. The residue S48, which is adjacent to H31 and C35 in the GSH-free structure (chain A), moves by more than 7 Å with GSH binding (chain B). Note, the view in B is rotated slightly from A. sulfenic acid intermediate was trapped, stabilized by the neighboring H31 imidazole. Although cysteine sulfenic acid fits, a cysteine plus a water molecule that interacted with both the cysteine thiol and the H31 imidazole fits better (Fig. 3A) . The crystals were grown in the presence of 0.25 mM DTT so they are expected to have reduced thiol at C35. However, it should be emphasized that there remains positive and negative Fo-Fc difference in density in and around the GSH-binding site, which suggests there may be an ensemble of minor states contributing to the diffraction pattern. It cannot be ruled out that among this ensemble of minor states there may be different oxidation states of cysteine.
A structural overlay of chains A and B near the GSHbinding site showed a large displacement of residues 39-51 by as much as 16 Å (Fig. 3B) . The N-terminal helix of the protein is shifted away from the center of the GSH site by 2.3 Å. Here, the most intriguing structural change is a switch from ␣-helical character for a four-residue region (V45 to S48) present in chain A, to random coil in chain B upon binding GSH. A noteworthy residue from this loop, S48, is adjacent to residues H31 and C35 in the GSH-free chain A (Fig. 3B) . Upon GSH binding the loop swings S48 away by 7 Å, suggesting this residue may be functionally important.
On chain A this site resembles several classes of phosphatases that utilize a cysteine nucleophile like the dual specific CDC25 or protein tyrosine phosphatase 1B (PTP 1B) (Wang et al. 2003) . CIB1 shares no consensus sequence or protein fold homology with these or any other phosphoryltransfer enzyme structures reported to date. On the basis of these phosphatases, which operate with a cysteine nucleophile, we speculate that functional residues of the CIB1 active site would be made up of at least H31, C35, and S48. Additionally, R32 is adjacent to this putative active site and could be mechanistically useful. Furthermore, several cysteine nucleophile phosphatases have been demonstrated to be redox regulated by GSH; for example, the active site cysteine of PTP 1B is glutathiolated (Barrett et al. 1999b ). The structure of CIB1 presented here with bound GSH, is suspiciously setup to serve a redox role, but we cannot rule out its presence as an artifact of purification. However, an initial phosphatase assay using p-nitrophenylphosphate as a substrate did not show evidence of activity, both in the presence and absence of ␣ IIb tail peptide (data not shown). This could be because p-nitrophenylphosphate is not a physiological substrate. It is plausible that a CIB1 phosphatase activity will only be activated upon binding to its physiological protein substrate. It should be noted that in addition to a seemingly redox sensitivity, CIB1 is already known to be highly regulated by multiple ions (Yamniuk et al. 2004) and binds multiple protein kinases (Wu and Lieber 1997; Kauselmann et al. 1999; Ma et al. 2003; Naik and Naik 2003a ).
Of interest is the known involvement of the ␣ IIb ␤ 3 integrin in the regulation of protein-tyrosine phophatases (Ezumi et al. 1995) . Recently it was shown that CIB1 and protein phosphatase-1 (PP1) have overlapping binding sites on the ␣ IIb cytoplasmic tail (Vijayan et al. 2004 ). Interestingly, PP1 is bound to this region in an unactivated state; in contrast, CIB1 binds only after activation of ␣ IIb ␤ 3 (Vallar et al. 1999; Tsuboi 2002; Naik and Naik 2003b; Vijayan et al. 2004) . Therefore, it is an attractive hypothesis that ␣ IIb acts in part as a location for phosphatases to regulate platelet aggregation. Phosphatases, such as PP1 and calcineurin, require association with a regulatory subunit to form distinct holoenzymes (Vijayan et al. 2004) . The ␣ IIb tail may act in this manner for both CIB1 and PP1. Interestingly, it has been shown that dephosphorylation of T753 of the cytoplasmic tail of integrin ␤ 3 is a necessary step during platelet activation (Lerea et al. 1999; Kirk et al. 2000) . It is interesting to speculate whether CIB1 serves as a phosphatase of this T753 residue upon its association with the ␣ IIb ␤ 3 integrin.
The presence of bound GSH outside the C35 and H31 site points to an alternate possible enzymatic role of CIB1. The C35 site of CIB1 may function as a single cysteine peroxiredoxin, where the cysteine would sense redox poise through a sulfenic intermediate (Poole et al. 2004 ). The structure of CIB1 bound GSH has a site that may be regulated by the formation and removal of a possible sulfenic intermediate form of C35. However, this possibility needs further exploration.
Concluding remarks
Since its discovery, CIB1 has been shown to associate with a myriad of proteins in platelets and other cells. Based on its homology to the CaM family of proteins it was believed that CIB1's role in signaling was limited to regulation through binding its partners. The crystal structure presented here suggests a putative enzymatic function for CIB1. Thus CIB1 may function either as a protein phosphatase or a single cysteine peroxiredoxin in order to regulate diverse functional proteins in a wide variety of cells. Furthermore, the bound GSH structure adds a novel redox regulated dimension to the physiological function of CIB1 so far understood. Study is underway to conclusively determine both the enzymatic function as well as the redox regulation of CIB1.
Materials and methods
Expression and purification of CIB1
Cloning and expression of full-length CIB1 (NCBI gi: 1848271) has previously been reported . The CIB1 protein was expressed as glutathione S-transferase fusion protein using Crystal structure of CIB1 www.proteinscience.org 1219 . Cells were resuspended in 20 mM Tris at pH 8.0, 500 mM NaCl, 1 mM phenylmethanesulfonyl fluoride, 10 g/mL aprotinin, 10 g/mL leupeptin, and 5 mM DTT. The CIB1 protein was purified using GSH-affinity chromatography (Amersham-Pharmacia) followed by column thrombin cleavage of the fusion protein with 25 units/mL of thrombin protease (Enzyme Research Laboratories) at 4°C. The proteolysis was carried out under reducing condition (5 mM DTT), thereby leading to the release of reduced GSH from the GSH-Sepharose resin, which is manufactured as oxidized glutathione. The thrombin protease was removed immediately using a benzamidine TRAP column (Amersham-Pharmacia). Dialysis was performed for 12 h in 5 mM HEPES at pH 7.5, 125 mM NaCl, 5 mM CaCl 2 , and 0.25 mM DTT. Protein was concentrated to 20 mg/mL, aliquoted, flashfrozen, and stored at −80°C until further use. The protein was purified in reduced conditions in the presence of DTT and degassed. We have observed, and it has also been suggested by other investigators, that a reducing environment is a key requirement for maintaining a native-like conformation of CIB1 (Yamniuk et al. 2004 ).
Crystallization of CIB1 and ⌬ −1-8 -CIB1
Crystallization trials were performed using the hanging-drop vapor diffusion method with the crystal screens 1 and 2 (Hampton Research). Our crystals with full-length CIB1 were found to be unreliable in terms of crystal growth and of poor diffraction quality. Secondary structure prediction using the program JPRED (www. compbio.dundee.ac.uk/∼www-jpred/) indicated a lack of secondary structure for the first 8 residues of the N terminus. We therefore truncated the N terminus of CIB1 so that it begins at residue 9. The resulting truncated form of the protein (⌬ −1-8 -CIB1) was purified as described above and used exclusively in the work reported. The best quality crystals of ⌬ −1-8 -CIB1 (200 × 100 × 100 m) were obtained with 20 mg/mL of ⌬ −1-8 -CIB1 in 3.0 M formate at pH 7.0, 50 mM HEPES at pH 7.0, 0.3 M NaCl, and 1% dimethylsulfoxide at 4°C. Of note, the presence of 0.25 mM DTT from the final dialysis step in the protein solution seemed to be critical for optimal crystallization. Addition of fresh DTT just before the crystallization trials or in excess of 1 mM during dialysis inhibited nucleation and crystal growth.
Cryo-conditions and introducing holmium for phasing
Crystals were frozen using liquid nitrogen in a cryo-solution made from the above crystallization solution by the addition of 15% glycerol. Holmium is known to replace calcium in EF-hands (Veenstra et al. 1995) and has been successfully used to solve structures by mutiwavelength anomalous diffraction (MAD) phasing (Weis et al. 1991) . We soaked crystals in Ca 2+ -free cryosolution containing 5 mM HoCl 3 for 24 h at 4°C.
MAD phasing crystal structure of CIB1
The crystallization conditions listed above yielded two different crystal forms (tetragonal and hexagonal). Crystal data were collected with a Rigaku RUH3R-Raxis IV system, at Brookhaven NSLS (beamlines ×12C, ×26, and ×25) and at APS beamline BIO-CARS 14-IDB. The data presented here are that of hexagonal crystals and were collected at APS from a single Ca 2+ -CIB1 crystal for a native data set extending to 2.3 Å resolution and a single Ho 3+ -CIB1 crystal for derivative data sets extending to 3.1 Å resolution. Data sets to 3.1 Å resolution were collected at the holmium L-absorption edge, at the fЉ peak value, and at a highenergy remote wavelength. The program SOLVE (Terwilliger and Berendzen 1999 ) was used to identify heavy atom sites and to phase the reflections to 3.1 Å. Four holmium sites and two subunits (chains A and B) of CIB1 were found in the asymmetric unit. Density modification starting from phases from the program SOLVE and including noncrystallographic symmetry (NCS) was performed using the program RESOLVE. The results from the program SCALEIT (Howell and Smith 1992; Collaborative Computational Project 1994) suggested that the derivative and native crystal structures were isomorphous. Hence, the Ca 2+ -CIB1 native amplitudes were combined with the Ho 3+ -CIB1 phases to 3.1 Å. Density modification in RESOLVE was begun at this resolution, and subsequently extended to the native data diffraction limit of 2.3 Å. RESOLVE was used to build a partial model of Ca 2+ -CIB1 (Terwilliger 2002) with about 85% of the residues modeled in.
The structure was refined in the program CNS by rigid body refinement, followed by simulated annealing using torsion angle dynamics (Brunger et al. 1998) . NCS restraints were initially applied. Programs O (Jones et al. 1991) and XtalView (McRee 1999) were used for model building. EF-hands 3 and 4 were fit with Ca 2+ and side chains were adjusted. Alternate steps of model building and refinement led to the complete placement of all protein atoms. During the water placement an unusually large region of positive difference electron density was observed near C35 of chain B and significant deviations from NCS in the N-terminal domain were noted. Residues 9-15 and 39-51 were problematic on the chain B because of the displacement caused by this region of electron density. It was apparent to us during the refinement process that this was most likely GSH considering the materials used for protein purification and crystallization. The density was modeled as GSH, which was supported by refinement. There is no corresponding GSH site near chain A, therefore we reasoned that this caused the large NCS deviations. As a result of these differences, NCS restraints during refinement were turned off. The CNS topology and parameter files for GSH were obtained from XPLO2D (Kleywegt and Jones 1997).
Water molecules were built in during successive cycles of model building, adjustment, and refinement. A final 2Fo-Fc annealed composite omit map for the Ca 2+ -CIB1 model was used to confirm the validity of the entire final model. The final R working and R free values were 0.236 and 0.251, respectively. Figures depicting protein structures were rendered using MOLSCRIPT (Kraulis 1991) , POVSCRIPT (Fenn et al. 2003) , and POVRAY (www.povray.org). Structure stereochemistry and data quality were validated using the programs PROCHECK and SFCHECK, respectively (Collaborative Computational Project 1994) . The atomic coordinates and structure factors for the structure of human CIB1 have been deposited in the Protein Data Bank (PDB; http:// www.pdb.org/) as entry 1Y1A.
